Fmr LLC Exelixis, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,700,317 shares of EXEL stock, worth $107 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,700,317

Previous 2,392,517 12.87%

Holding current value

$107 Million

Previous $88.3 Million 34.75%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$34.13 - $46.26 $10.5 Million - $14.2 Million	307,800 Added 12.87%	2,700,317 $119 Million
Q1 2025 May 12, 2025	SELL	$32.38 - $39.16 $18 Million - $21.7 Million	-555,082 Reduced 18.83%	2,392,517 $88.3 Million
Q4 2024 Feb 13, 2025	BUY	$25.39 - $36.46 $12.3 Million - $17.7 Million	485,527 Added 19.72%	2,947,599 $98.2 Million
Q3 2024 Nov 13, 2024	BUY	$21.96 - $27.6 $3.09 Million - $3.88 Million	140,568 Added 6.06%	2,462,072 $63.9 Million
Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $7.3 Million - $8.52 Million	359,087 Added 18.3%	2,321,504 $52.2 Million
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $22.4 Million - $26.6 Million	-1,109,602 Reduced 36.12%	1,962,417 $46.6 Million
Q4 2023 Feb 13, 2024	BUY	$19.25 - $24.13 $3.61 Million - $4.53 Million	187,595 Added 6.5%	3,072,019 $73.7 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $4.7 Million - $5.61 Million	246,605 Added 9.35%	2,884,424 $63 Million
Q2 2023 Aug 11, 2023	SELL	$18.17 - $20.48 $60.6 Million - $68.3 Million	-3,334,080 Reduced 55.83%	2,637,819 $50.4 Million
Q1 2023 May 11, 2023	SELL	$16.3 - $19.41 $115 Million - $137 Million	-7,078,279 Reduced 54.24%	5,971,899 $116 Million
Q4 2022 Feb 13, 2023	SELL	$14.96 - $17.39 $37.8 Million - $44 Million	-2,527,392 Reduced 16.22%	13,050,178 $209 Million
Q3 2022 Nov 10, 2022	SELL	$15.68 - $22.27 $28.5 Million - $40.5 Million	-1,819,716 Reduced 10.46%	15,577,570 $244 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $3.44 Million - $4.57 Million	197,254 Added 1.15%	17,397,286 $362 Million
Q1 2022 May 13, 2022	SELL	$17.03 - $22.67 $27.3 Million - $36.4 Million	-1,604,948 Reduced 8.53%	17,200,032 $390 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $134,671 - $186,023	-8,502 Reduced 0.05%	18,804,980 $344 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $21 Million - $27.2 Million	-1,288,106 Reduced 6.41%	18,813,482 $398 Million
Q2 2021 Aug 13, 2021	BUY	$17.95 - $25.56 $361 Million - $514 Million	20,101,588 New	20,101,588 $366 Million

Others Institutions Holding EXEL

# of Institutions

686

Shares Held

260M

Call Options Held

1.41M

Put Options Held

1.55M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account